Work

Phase II study of the Src kinase inhibitor saracatinib (AZD0530) in metastatic melanoma

Year: 2012

Type: article

Study design: Clinical Trial

Source: Investigational New Drugs

DOI: 10.1007/s10637-012-9897-4

Authors: Tara C. Gangadhar, Joseph I. Clark, Theodore Karrison, Thomas F. Gajewski

Institutions: University of Chicago, University of Pennsylvania, Loyola University Chicago

Language: English

Topic: Melanoma and MAPK Pathways

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: green

Funders: National Institutes of Health, National Cancer Institute

Awards: G1964418830, G371985182, Early Therapeutics Development with Phase II Emphasis

OpenAlex ID: W2092684062

FWCI: 1.858

Cites: 11

Cited by: 57

Related to: 10